Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.
about
Recent advances in the neuropsychopharmacology of serotonergic hallucinogensInvestigating the Role of Serotonin in Methamphetamine Psychosis: Unaltered Behavioral Effects of Chronic Methamphetamine in 5-HT1A Knockout Mice.Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.Altered exploration and sensorimotor gating of the chakragati mouse model of schizophrenia.Serotonergic hallucinogens as translational models relevant to schizophrenia.Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders.The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.Effect of Hallucinogens on Unconditioned Behavior.A Physician's Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT).Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
P2860
Q27027381-FC04DF00-D42D-434F-8E57-B7B1E4E967DBQ30357167-ECCB2A0F-D145-48C7-9D6B-C8E372FF616BQ30358201-F6A5CA33-3949-449E-8FDC-75D0115ADAABQ30405594-87EBBA07-522F-4E78-BA69-FDED672C350CQ30427074-B33AD6A2-1BDA-4D1E-BBF6-89500B7AD865Q30459497-A44C7BEF-4371-4362-B090-D7A0EF095AEDQ34660497-F3FCD486-C831-4135-A982-57D563BEF381Q35025821-05157CB2-7006-4B6B-8EDE-D584D1561E80Q36844764-39D11353-7D81-412B-9FEE-92491FF0D5E9Q45279141-B4B047D3-93C0-45A2-ABF4-1A5CA6C03658Q47674493-B40CF3C1-0448-4A9C-8D93-F65F357B8615Q52307553-9F3E7E51-91D4-4FA3-8839-4B55CFFFD4B6
P2860
Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@ast
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@en
type
label
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@ast
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@en
prefLabel
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@ast
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@en
P2093
P2860
P1433
P1476
Enhanced effects of amphetamin ...... mplications for schizophrenia.
@en
P2093
Adam L Halberstadt
Emma Ruimschotel
Maarten van den Buuse
Sally Martin
Victoria B Risbrough
P2860
P304
P356
10.1016/J.NEUROPHARM.2011.04.001
P577
2011-04-12T00:00:00Z